JD Health International マネジメント
マネジメント 基準チェック /34
現在、CEO に関する十分な情報がありません。
主要情報
Enlin Jin
最高経営責任者
CN¥8.4m
報酬総額
| CEO給与比率 | 15.0% |
| CEO在任期間 | 3.2yrs |
| CEOの所有権 | 0.01% |
| 経営陣の平均在職期間 | データなし |
| 取締役会の平均在任期間 | 4yrs |
経営陣の近況
Recent updates
Investors Appear Satisfied With JD Health International Inc.'s (HKG:6618) Prospects
Nov 04
Is Now An Opportune Moment To Examine JD Health International Inc. (HKG:6618)?
Sep 26A Look At The Fair Value Of JD Health International Inc. (HKG:6618)
Sep 05Results: JD Health International Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts
Aug 19The Returns On Capital At JD Health International (HKG:6618) Don't Inspire Confidence
Aug 08Why We're Not Concerned About JD Health International Inc.'s (HKG:6618) Share Price
Jul 21This Is Why JD Health International Inc.'s (HKG:6618) CEO Compensation Looks Appropriate
Jun 14Calculating The Intrinsic Value Of JD Health International Inc. (HKG:6618)
May 21JD Health International Inc.'s (HKG:6618) Stock Retreats 30% But Earnings Haven't Escaped The Attention Of Investors
Apr 17JD Health International (HKG:6618) Is Reinvesting At Lower Rates Of Return
Apr 08At HK$29.80, Is It Time To Put JD Health International Inc. (HKG:6618) On Your Watch List?
Mar 01Revenues Tell The Story For JD Health International Inc. (HKG:6618)
Jan 16JD Health International (HKG:6618) Will Want To Turn Around Its Return Trends
Dec 07What Does JD Health International Inc.'s (HKG:6618) Share Price Indicate?
Nov 20JD Health International Inc. (HKG:6618) Shares Could Be 44% Below Their Intrinsic Value Estimate
Nov 02Be Wary Of JD Health International (HKG:6618) And Its Returns On Capital
Aug 21JD Health International Inc.'s (HKG:6618) Intrinsic Value Is Potentially 32% Above Its Share Price
Aug 03JD Health International Inc.'s (HKG:6618) Price In Tune With Revenues
Jun 08Is JD Health International Inc. (HKG:6618) Trading At A 32% Discount?
Apr 19Estimating The Intrinsic Value Of JD Health International Inc. (HKG:6618)
Dec 29Is There An Opportunity With JD Health International Inc.'s (HKG:6618) 31% Undervaluation?
Sep 14A Look At The Fair Value Of JD Health International Inc. (HKG:6618)
Dec 04Calculating The Fair Value Of JD Health International Inc. (HKG:6618)
Mar 08CEO報酬分析
| 日付 | 総報酬 | 給与 | 会社業績 |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | CN¥3b |
| Mar 31 2024 | n/a | n/a | CN¥2b |
| Dec 31 2023 | CN¥8m | CN¥1m | CN¥2b |
| Sep 30 2023 | n/a | n/a | CN¥2b |
| Jun 30 2023 | n/a | n/a | CN¥2b |
| Mar 31 2023 | n/a | n/a | CN¥1b |
| Dec 31 2022 | CN¥8m | CN¥1m | CN¥380m |
| Sep 30 2022 | n/a | n/a | -CN¥7m |
| Jun 30 2022 | n/a | n/a | -CN¥395m |
| Mar 31 2022 | n/a | n/a | -CN¥734m |
| Dec 31 2021 | CN¥3m | CN¥301k | -CN¥1b |
報酬と市場: Enlinの 総報酬 ($USD 1.16M ) は、 Hong Kong市場 ($USD 906.43K ) の同様の規模の企業の平均とほぼ同じです。
報酬と収益: Enlinの報酬は、過去 1 年間の会社の業績と一致しています。
CEO（最高経営責任者
Enlin Jin (43 yo)
3.2yrs
在職期間
CN¥8,385,000
報酬
Mr. Enlin Jin is Chief Executive Officer & Executive Director of JD Health International Inc. from September 06, 2021. Mr. Jin has extensive experience in pharmaceuticals and TMT industry. He serves as the...
取締役
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| CEO & Executive Director | 3.2yrs | CN¥8.39m | 0.011% HK$ 9.2m | |
| Independent Non-Executive Director | 2.6yrs | CN¥818.00k | 0.00030% HK$ 254.6k | |
| Chairman | 4.2yrs | CN¥407.82m | 0.56% HK$ 471.4m | |
| Non-Executive Director | 4.3yrs | データなし | データなし | |
| Independent Non-Executive Director | 4yrs | CN¥476.00k | 0.00018% HK$ 152.8k | |
| Independent Non-Executive Director | 4yrs | CN¥476.00k | 0.00018% HK$ 152.8k | |
| Independent Non-Executive Director | 3.7yrs | CN¥463.00k | 0.00019% HK$ 161.2k |
4.0yrs
平均在職期間
51yo
平均年齢
経験豊富なボード: 6618の 取締役会 は 経験豊富 であると考えられます ( 4年の平均在任期間)。